Actively Recruiting
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Led by Viome · Updated on 2025-01-29
475
Participants Needed
1
Research Sites
235 weeks
Total Duration
On this page
Sponsors
V
Viome
Lead Sponsor
N
New York Medical College
Collaborating Sponsor
AI-Summary
What this Trial Is About
To evaluate the design, safety and efficacy of OralViome Cancer Testing system in the early detection of Oral and Throat Cancers using saliva metatranscriptomic analysis. This study will recruit only at existing clinical sites and will NOT use any additional clinical sites.
CONDITIONS
Official Title
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed Informed Consent obtained
- 18 years and older
- At a high risk of developing oral or throat cancer based on clinician's discretion
You will not qualify if you...
- Pregnancy
- Use of fertility enhancing medications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NYMC
New York, New York, United States, 10595
Actively Recruiting
Research Team
M
Mory Mehrtash, MSc
CONTACT
M
Momchilo Vuyisich, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here